chemical has protein target as antagonist molecular entity Polyman26 PM26 A multivalent glycomimetic mannoside that can act as a glycomimetic antagonist by interaction with DC-SIGN (i.e., CD209 antigen). The DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection, which can be inhibited by PM26, a glycomimetic antagonist. Easheta Shah, Roshan Desai, Oliver He https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009576 CD209 antigen (human)